Search Within

Joachim Yahalom

  1. "2004"
Formats
  1. Book Section (7)
  2. Journal Article (7)
  3. Meeting Abstract (6)
Groups
  1. Radiation Oncology, Department of (20)
  2. Survivorship Research (20)
  3. Center for Hematologic Malignancies (11)
  4. Department of Medicine (11)
  5. Hematologic Malignancies, Division of (11)
  6. Lymphoma (11)

More Groups

People
  1. Andrew Zelenetz (8)
  2. Carol Portlock (8)
  3. Craig Moskowitz (7)
  4. David Straus (7)
  5. Ariela Noy (5)
  6. Jing Qin (4)

More People

Years
  1. 2004 (20)
Publications
  1. Blood (4)
  2. Journal of Clinical Oncology (3)
  3. Non-Hodgkin's Lymphoma (3)
  4. British Journal of Haematology (2)
  5. Leibel and Phillips Textbook of Radiation Oncology. 2nd ed (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. American Society of Clinical Oncology (3)
  3. Lippincott Williams & Wilkins (3)
  4. John Wiley & Sons (2)
  5. Saunders Elsevier (2)
  6. CMP Healthcare Media (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients with primary CNS lymphoma (PCNSL)
    Meeting Abstract

    El Kamar, F. G.; Deangelis, L. M.; Yahalom, J.; Correa, D. D.; Grant, B. W.; Larocca, R. V.; Raizer, J. J.; Schiff, D.; Abrey, L. E.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • FDG-PET scanning for detection, staging and treatment planning of extranodal marginal zone lymphomas
    Meeting Abstract

    Beal, K. P.; Yeung, H. W.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2004)

    Fulltext@MSK | Save
  • Bronchial-associated lymphoid tissue (BALT) lymphoma: Characteristics and treatment outcome of 19 cases
    Meeting Abstract

    Beal, K. P.; Portlock, C.; Yahalom, J.
    Blood (2004)

    Fulltext@MSK | Save
  • Excellent long-term experience with primary bone lymphoma: Analysis of prognostic factors
    Meeting Abstract

    Beal, K. P.; Allen, L. F. H.; Yahalom, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease
    Journal Article

    Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Gonzalez, M.; Zelenetz, A. D.; Yahalom, J.
    British Journal of Haematology (2004)

    Fulltext@MSK | Save
  • Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease
    Journal Article

    Portlock, C. S.; Donnelly, G. B.; Qin, J.; Straus, D.; Yahalom, J.; Zelenetz, A.; Noy, A.; O'connor, O.; Horwitz, S.; Moskowitz, C.; more...
    British Journal of Haematology (2004)

    Fulltext@MSK | Save
  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Non-Hodgkin's lymphoma: Clinical practice guidelines
    Journal Article

    Zelenetz, A. D.; Appelbaum, F. R.; Buadi, F.; Cabanillas, F.; Caligiuri, M. A.; Czuczman, M. S.; Damon, L. E.; Finn, I. E.; Forero, A.; Glenn, M. J.; more...
    Journal of the National Comprehensive Cancer Network (2004)

    Fulltext@MSK | Save
  • The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
    Journal Article

    Portlock, C. S.; Qin, J.; Schaindlin, P.; Roistacher, N.; Myers, J.; Filippa, D.; Louie, D.; Zelenetz, A. D.; O'Brien, J. P.; Moskowitz, C.; more...
    Annals of Oncology (2004)

    Fulltext@MSK | Save
  • Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
    Journal Article

    Straus, D. J.; Portlock, C. S.; Qin, J.; Myers, J.; Zelenetz, A. D.; Moskowitz, C.; Noy, A.; Goy, A.; Yahalom, J.
    Blood (2004)

    Fulltext@MSK | Save